Reliance Jio is reportedly considering a major shift in its IPO approach: instead of existing investors selling shares, the company could issue fresh shares. That would route proceeds directly into Jio Platforms, potentially for debt reduction and expansion. Investors are watching closely, as this could rebuild confidence in India’s biggest IPOs and set a new playbook for future mega listings.
Biocon’s Executive Chairperson Kiran Mazumdar-Shaw has mapped a five-year succession plan, naming her niece Claire Mazumdar as successor. The company expects a strong FY27 launch calendar, especially in the second half, driven by its “diabesity” franchise. It also reports significant debt reduction and will channel more operational cash flow toward further deleveraging as it targets a semaglutide push from FY28.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Vedanta says it has delivered record Q4 profit and expects FY27 to stay strong. The company plans a major debt reduction, continued expansion investments and shareholder rewards, with leverage projected to hit a new low. It’s also moving ahead with its demerger, setting up four new firms to list soon, with some units potentially debt-free post-demerger.
Vedanta Resources is reportedly in talks to increase its existing $350 million loan by at least $200 million, potentially with Sumitomo Mitsui Banking Corp. and First Abu Dhabi Bank joining the facility. The company says the funds would help refinance obligations, cover transaction costs, and meet general corporate needs as it continues efforts to reduce debt.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
